107
hearings and to enjoin the prosecutions. See United States v. Bally, No. 17-20135, 2017 WL 5625896, at *4 (E.D. Mich. Nov. 22, 2017); United States v. Samp, No. 16-CR-20263, 2017 WL 1164453 at *1 (E.D. Mich. Mar. 29, 2017); United States v. Ragland, No. 15-CR-20800, 2017 WL 2728796 at *1 (E.D. Mich. June 26, 2017). These cases all stem from Michigan, which has had a medical cannabis program in place for some time, and give Ohio healthcare providers a guide as to how federal prosecutions will be handled here.
Therefore, Ohio hospitals planning to allow medical cannabis use on their premises, or to be recommended by their physicians, need to be prepared to show documentation, policies, and procedures that such medical cannabis conduct is in strict compliance with Ohio’s medical cannabis law (O.R.C. 3796, et seq.). Preparing these policies and procedures will require an in-depth understanding of Ohio’s medical cannabis program and the federal cannabis laws. This exercise should be completed by each Ohio hospital before medical cannabis, in one way or another, shows up on your doorstep in September of this year.
Our health law industry team has lawyers dedicated to understanding the Ohio medical cannabis law and the federal cannabis laws. We have helped healthcare providers and institutions prepare for the new form of treatment and have the knowledge to help hospitals with the transition as well.
For more information on
Ohio’s medical cannabis law
please contact:
Brian Higgins
513-651-6839
Frost Brown Todd’s
Health Care industry team